Adolescent/young adult SIG
|
|
The Adolescent/Young Adult (AYA) SIG is an opportunity for paediatric and adult health professionals caring for adolescents and young adults with rheumatological disease to meet with, listen to and learn from one another.The AYA SIG is linked closely to the Barbara Ansell National Network for Rheumatology (BANNAR).
This SIG aims to promote high quality, young person-friendly, developmentally appropriate health services and understand the challenges of ensuring this care is continually provided. The group also explores how young person friendly, developmentally appropriate services have been achieved in different centres across the UK and reviews recent advances relevant to the care and long-term health outcomes of young people with rheumatological disease.
The AYA SIG does not have a formal membership. Clinicians expressing an interest in joining the group are directed to BANNAR. BANNAR meets twice yearly and has very clearly defined aims, objectives and terms of reference. Meetings are targeted at all stakeholders engaged with delivering or advancing the care of adolescents and young adults with rheumatological diagnoses. The group meets annually for a planned programme of teaching, chosen in conjunction with the BANNAR membership. The meeting is coordinated by the SIG convenors.
|
Artificial Intelligence (AI) SIG
|
|
There's a growing interest in the potential for recent developments in artificial intelligence to impact on healthcare, including the practice of rheumatology, but how do we distil the robust science from the science fiction hype?
The Artificial Intelligence SIG is a community of clinicians, researchers and patients with an interest in artificial intelligence and data science and provides a forum for sharing developments in the field, hearing about the latest research and planning engagement and educational activities.
We hold a quarterly online meeting that includes introductions for new members, a discussion of recent developments in Rheumatology AI, a keynote speaker presentation, and collaborative planning for future activities. In addition to these regular meetings, we also aim to host a one-day conference focused on “Musculoskeletal Artificial Intelligence” at The Alan Turing Institute in London.
Sign up to hear more.
Convenors: Nicholas Fuggle, Meghna Jani and Jordan Tsigarides
|
B-cells and B-cell targeted therapies SIG
|
|
This SIG provides an opportunity to meet, learn with and increase collaboration between adult and paediatric and adolescent rheumatologists and scientists with a special interest in B-cells and B-cell targeted therapies. One of the group’s aims is to educate the community regarding up-to-date knowledge on these therapies, their current use, and ongoing research projects, given that optimal use of B-cell targeted therapies and their long-term safety is still not well established.
There is a large potential for the development of more effective and/or safer B-cell targeted therapies for the treatment of autoimmune rheumatic diseases as new drugs continue to be developed in particular for the treatment of malignancies of B-cell origin. This SIG works to contribute to writing Best Practice guidelines in this area and establish collaborations with other specialities including haematologists, clinical immunologists and infectious disease specialists to contribute to safer use of these therapies and to possible development of new therapies.
Convenors: Dr Maria Leandro, Dr Venkat Reddy and Dr Edward Vital
|
Cardiovascular comorbidities in rheumatoid arthritis SIG
|
|
The Cardiovascular comorbidities in rheumatoid arthritis SIG works to exchange information on current research and practice work streams, facilitates the exchange of ideas and the development of collaborating small or large networks to help provide answers to specific research questions, develop, implement and evaluate relevant guidelines and practice changes to the benefit of patients with RA.
Cardiovascular disease (CVD) is one of the main co-morbidities and a principal cause of mortality in rheumatoid arthritis (RA). The causes for this are still not clear, but classical CVD risk factors, systemic inflammation and other factors peculiar to RA (e.g. genes and therapies) all appear to play an important role. Pharmacological and lifestyle interventions for control of these risk factors are of importance
Convenor: Dr Jet Veldhuijzen van Zanten
|
Crystal arthritis SIG
|
|
The Crystal Arthritis SIG was founded in 2017 and aims to provide a focus and leadership for gout and calcium pyrophosphate crystal deposition within the BSR. Led by Ed Roddy, Abhishek Abhishek and Kelsey Jordan, we ensure a high profile for crystal arthritis at the BSR’s annual conference and provide regular educational updates for rheumatologists, trainees and health professionals in rheumatology and primary care to share best practice and improve the management of these common but neglected conditions.
The SIG seeks to facilitate the exchange of ideas and information, promote the development of collaborative research and quality improvement projects, and link to international crystal arthritis networks in Europe (European Crystal Network) and the USA (Gout-Crystal Arthritis Network). We support the BSR to deliver its Complex Crystal Arthritis one-day course and have supported other important initiatives such as the 2022 NICE gout diagnosis and management guideline.
We are currently a growing group with 17 members and are very keen to attract new members at all stages of their career, especially early career colleagues. Crystal Arthritis SIG members will receive 2-3 email updates per year about key advances in the field.
For further information, please email crystalarthritissig@outlook.com or sign up to join the Crystal Arthritis SIG mailing list.
Convenors: Dr Edward Roddy
|
Education SIG
|
|
The Education SIG meets online three to four times a year, with an additional face-to-face meeting held during the BSR annual conference. The group focuses on sharing best practices, primarily in undergraduate education, but also in the training of Specialist Registrars (SpRs) and Allied Health Professionals (AHPs). Comprising a diverse mix of doctors, nurses, and AHPs, the group also undertakes some collaborative research, although there are no specific requirements for members to participate. With around 15 members currently involved, the group is always keen to welcome new participants.
If you are interested in joining, please contact our convenors: David Coady or Pippa Watson.
|
Ethnicity SIG
|
|
The purpose of this SIG is to advance knowledge and understanding about rheumatological conditions and patient care for patients of minority ethnic groups. The group considers ethnic variations in perception, awareness and acceptance of conditions, explores patient education needs in minority ethnic groups and the development of patient education material in local languages, and promotes local resources for patient information and support.
Convenor: Arumugam Moorthy
|
Foot and ankle SIG
|
|
The Foot and Ankle SIG attracts a diverse range of disciplines including medical practitioners and researchers in different fields (e.g. rheumatology, orthopaedics), allied health professionals, bioengineers, epidemiologists and others.
There's a growing body of knowledge in this previously poorly understood area of practice and it is attracting rising interest. The objectives of this group are to identify areas of common concern and devise strategies for their solution, provide opportunities for the development of collaborative research projects, a forum for discussion of ongoing work and developing consensus-based statements or standards, work in evolution or the development of new ideas.
The group convenes an annual meeting of the group and other interested parties.
Convenors: Dr Edward Roddy and Dr Lindsey Cherry
|
Hypermobility Syndromes SIG
|
|
This SIG covers all hypermobility related disorders including Hypermobility Spectrum Disorder, Ehlers-Danlos syndromes, Marfan syndrome, Osteogenesis imperfecta as well as associated co-mobidities including fibromyalgia and chronic widespread pain, dysautonomia (particularly PoTS), Gastrointestinal symptomatology, mast cell activation syndrome and Neurodiversity.
The group welcomes participation from all those interested in complex multi-system disease, clinical genetics, rehabilitation, and pain management. It aims to hold meetings in association with our Annual Conference and ACR's, and to support regional meetings on a regular basis.
Convenor: Dr Philip Bull
|
Hyperinflammation SIG
|
|
The Hyperinflammation SIG aims to highlight the crucial role that rheumatologists play in the management of complex inflammatory disease and hyperinflammatory syndromes across the life course.
The group plans to use its network to focus on the particular skills and expertise needed to manage haemophagocytic lymphohistiocytosis and other hyperinflammatory syndromes through a programme of education and training. The SIG will work to improve patient management through the development of a national network of MDTs which in turn facilitate multi-centre research.
Interested in joining? Contact convenors: Dr Jessica Manson, Dr Rachel Tattersall
|
Infections in rheumatology SIG
|
|
Rheumatology has many pertinent infections-related issues. Immunosuppressant agents including the biologic therapies have transformed the management of various rheumatological conditions; however, infections in immunocompromised patients is a major concern. The Infections in Rheumatology SIG aims to provide a focused forum for clinical, educational and research purposes.
The aims of the SIG are to provide a forum for those interested in infections in rheumatology, offer rheumatologists an opportunity to broaden their knowledge and keep abreast of the latest developments, establish close links with national experts in the fields of microbiology, infectious diseases, orthopaedics, musculoskeletal radiology and nuclear medicine and to promote collaborative research and form close links with our biologics registers and contribute to the development of clinical guidelines.
Convenors: Dr Graham Raftery and Dr Muddassir Shaikh
|
Lung and rheumatic disease SIG
|
|
The BSR Lung SIG was formed in 2015 in response to the rapidly growing interest in lung diseases associated with rheumatic disorders, and it has expanded exponentially over the subsequent decade. Although we have a broad interest across the range of respiratory conditions encountered by rheumatology patients, our present major focus is on the interstitial lung diseases (ILDs) associated with systemic autoimmune rheumatic disorders (SARDs). Several of our Core Group of clinicians are presently involved in helping to shape the BSR / BTS guidelines for the diagnosis, monitoring and management of SARD-ILD. This involves a close working relationship with our respiratory colleagues. SIG members have published several papers on this subject and our publications have also included extensive work on other conditions such as bronchiectasis. Several of us are actively involved in clinical research and many undertake regular joint multidisciplinary clinics with our respiratory colleagues.
Our open SIG meeting at BSR regularly attracts several hundred delegates, and we meet virtually and informally to discuss ideas and projects. We are very happy to include all interested clinicians, from all backgrounds whether medical, or working in allied professions. Members of the BSR Lung SIG can anticipate the opportunity to learn from and contribute to clinical research and the sharing of clinical innovations. We currently have around 30 core group members and many more affiliated members who attend our annual meetings.
Our Core Group agenda on 15 July included two new proposals. Firstly, to allow Rheumatologists to access the SARD-ILD section of the BTS national audit on ILD, both to enter data on their patients and to access and analyse data already entered. Secondly, to audit BSR members' experiences of, and involvement in, joint lung MDTs with a view to publishing our shared findings. Details of our autumn meeting at which we plan to share progress in these areas will be available shortly.
Contact us to join.
Convenor: Dr Clive Kelly, Mark Garton, Gouri Koduri
|
Myositis SIG
|
|
The BSR Myositis SIG has approximately 130 members and aims to enhance knowledge on the diagnosis and management of idiopathic inflammatory myopathies. We foster collaborative working to support best practice and access to clinical trials. The group is closely linked to UKMyonet, a network of UK health professionals with an interest in idiopathic inflammatory myopathies in addition to international organisations including IMACS, ENMC and iMyos. Meetings typically include short presentations covering the latest research and clinical challenges with opportunities for questions and discussion. Meetings are open to all and are held biannually, coinciding with the BSR annual conference in spring and a UKMyonet meeting in the autumn.
Convenors: Sarah Tansley or Harsha Gunawardena
|
Osteoarthritis SIG
|
|
Osteoarthritis (OA) is the most common form of joint disease worldwide and it continues to gain increased attention due to its clinical burden. This SIG aims to share new developments in OA. It's targeted at members with an interest in advancing research in this area. The objectives of the group are to promote development and dissemination of relevant guidelines and research, as well as public information about OA, to implement changes of best clinical practice and determine future directions of research in OA.
Convenor: Prof Mel Holden and Nidhi Sofat
|
Osteoporosis and Metabolic Bone Disease SIG
|
|
The Osteoporosis SIG aims to provide regular updates for general rheumatology practitioners on osteoporosis and metabolic bone disease. The SIG aims to highlight the importance of osteoporosis and ensures that this key specialist area maintains a high profile at BSR Annual Conference.
We also keep members updated on key events and outputs in the bone community, getting feedback on ideas for conference, surveying members about current practice and needs, and coordinating responses to new policy documents in the field of osteoporosis, including NICE guidance. This ensures the views of practicing rheumatology practitioners with an interest in osteoporosis are taken into account.
Meetings are targeted at rheumatologists, resident doctors, nurse specialists and allied health professionals working in the field of rheumatology and bone health. By getting involved in the SIG you will be kept up to date with news relevant to the bone field as well as contributing to development of osteoporosis and metabolic bone disease policies and practice.
We meet in person at the main Conference and are considering six-monthly online meetings. If you would like more information, please email convenors: Prof Zoe Paskins and Prof Kassim Javaid
|
Pain SIG
|
|
The Pain Special Interest Group (SIG) is a welcoming, multidisciplinary community working together to improve the understanding and management of pain in rheumatological and musculoskeletal (MSK) conditions through evidence-based care and research.
Why you should get involved:
- Stay up to date with the latest developments in pain research and treatment
- Connect with a multidisciplinary network of like-minded professionals
- Share your own clinical or research insights
- Collaborate on projects
We meet twice a year - at the BSR Annual Conference – with expert talks and time for discussion and collaboration and online in the Autumn – a more informal space to exchange ideas, showcase work, and connect. Already 50+ members strong and growing – find out more today here.
Convenors: Dr Ian Scott and Dr Zoe Rutter-Locher
|
Physical activity SIG
|
|
This sport and exercise medicine SIG focuses on the latest evidence surrounding physical activity and the importance of promoting and delivering interventions amongst patients with rheumatological conditions. Physical activity has been shown to be an effective intervention for patients with a variety of rheumatology conditions to improve challenging symptoms including fatigue, stiffness, and pain, but prescription is currently underutilised in the NHS and amongst rheumatology patients.
The aims of this SIG are to focus on the latest evidence on the benefits of physical activity related to OA, inflammatory rheumatic disease, and MSK pain and demonstrate models of care where physical activity has been incorporated into patient pathways to inspire clinicians to consider how they can integrate these concepts into their own practice. The group also explores effective strategies in consultations to motivate patients to be more active. In turn, it aims to generate awareness, to enable promotion, education, dissemination and utilisation of the Faculty of Sport and Exercise Medicine Inflammatory Rheumatic Disease Moving Medicine Module for Health Professionals to use with patients.
Meetings are targeted at all healthcare professionals working with rheumatology patients, including doctors, physiotherapists, specialist nurses and occupational therapists. It will also be of interest to patient representatives. Get involved here.
Convenor - Raj Amarnani
|
Pregnancy and rheumatic diseases SIG
|
|
The Pregnancy and Rheumatic Diseases SIG aims to improve the quality of care and management of rheumatic disease pre-conception, through pregnancy and postnatally by providing educational updates for rheumatologists, trainees and health professionals on the interplay between rheumatic diseases and pregnancy, sharing current research and best practice.
We currently have around 50 members. Members receive a quarterly newsletter, which highlights:
- Key academic papers, clinical guidelines and research opportunities
- Relevant webinars, podcasts, conferences and events
- Useful resources for delivering pregnancy and reproductive care in rheumatology
We're currently collaborating with the UK Teratology Information Service (UKTIS) to improve the information available on medication safety in rheumatic disease pregnancies. We are also considering broadening the remit of the SIG to cover reproductive health more broadly – including fertility, contraception, and menopause – for both males and females, and to reflect this in future educational activities.
We submit a session to the British Society for Rheumatology annual conference each year and welcome member input into the content of that session.
To join the SIG and receive the newsletter, members can simply email one of our co-chair convenors: Maria Mouyis, Beth Goulden, Prof Giles
|
Quality improvement SIG
|
|
The quality improvement SIG aims to support all members of the paediatric and adult rheumatology MDT to gain confidence and expertise in using QI methodology, with the ultimate aim of improving patient care and clinician experience. We provide a number of educational opportunities including formal QI methodology courses and more informal QI drop-in clinics, where anyone working in rheumatology is welcome to join us to discuss QI projects and learn from others.
We have produced a number of resources available on the BSR website and e-learning platform, ranging from an update on QI tools to exemplar projects from across the MDT.
We aim to expand our growing network of QI experts and enthusiasts and to provide new approaches to the challenges faced in clinical practice. We try to embed QI methodology aligned, where possible, to local trust priorities and national projects. Please get in touch with any of the convenors if you would like to hear more and be added to our mailing list.
Convenors: Charlotte Sharp, Roz Benson, Elizabeth MacPhie, Jo Ledingham, Flora McErlane, Gavin Cleary
|
Rheumatoid arthritis SIG
|
|
Our RA SIG brings together clinicians, researchers, and patient advocates to drive innovation, equity, and excellence in RA care. Group discussions focus on a spectrum of clinical and research opportunities and priorities, and how these can be used in deliberations with funding bodies, the BSR clinical affairs team and NICE.
Our mission is to:
- Promote cutting-edge clinical and research insights to enhance patient outcomes.
- Champion the voices of people living with RA through strong patient advocacy and partnership.
- Address health inequities by recognising and tackling the social determinants of health that shape disease impact and access to care.
- Foster collaboration across disciplines, with a shared vision of improving quality of life for all individuals affected by RA.
- Whether your interest lies in clinical care, education, research, or policy, there’s a place for you in this dynamic and purpose-driven community.
- Let’s shape a future where everyone with RA receives the care and support they need—no matter who they are or where they live.
We host a two-hour meeting at the annual BSR congress and additional online/face-to-face meetings throughout the year (dates to be confirmed) with a pre-agreed agenda.
For anyone interested, please email: Elena Nikiphorou.
|
Rheumatology in low and middle income countries SIG
|
|
Join our Rheumatology in LMIC SIG which brings together a collaborative, friendly, and international community of professionals dedicated to promoting research, training, and service development in LMICs.
What we do:
- Champion rheumatology in LMICs
- Share and shape research through global collaboration
- Support service provision and training initiatives
- Partner with AFLAR and other global bodies
- Run webinars, work with the BSR to increase LMIC engagement (eg. offering complimentary membership to LMIC colleagues) & we are currently developing a podcast
Meetings at the Annual Conference are an open format with a mix of structured agenda and space for idea exchange. Get involved and sign up to our newsletter here.
Convenors: Professor Robert Moots, Dr Mwidimi Ndosi, Dr Zoe Rutter-Locher and Dr Fred Otieno
|
Scleroderma SIG
|
|
The Scleroderma SIG aims to provide updates on recent clinical trials and increase understanding of current assessment of scleroderma vascular disease. The group aims to continue to foster close links with other relevant groups such as Scleroderma & Raynaud’s UK (SRUK) and UK Scleroderma Study Group (UKSSG), provide guidance about investigation and treatment of systemic sclerosis, highlight key challenges and opportunities in trial design and disease assessment and consider barriers that must be overcome to support successful clinical trial programmes for cutaneous vascular manifestations of systemic sclerosis.
Meetings are targeted at people who have a clinical and research interest in scleroderma.
Convenor: Prof Chris Denton
|
Sjögren's syndrome SIG
|
|
|
The Sjogren’s SIG is an informal group of individuals with an interest in Sjogren’s. We put together a programme for the Annual Conference each year which aims to cover some of the basics and update participants on what’s new in Sjogren’s. We usually get a good turnout of anything upwards of 100 delegates attending the sessions. We try and include local experts where possible and have also invited other specialties who see patients with Sjogren’s e.g. ophthalmologists, oral medicine specialists, renal physicians and neurologists. We don’t have formal meetings outside of the annual meeting but have drawn on interested individuals to participate in the Guideline process. If you are interested in getting involved – either in designing the sessions for the annual meeting or in running a more formalised SIG then please get in touch with convenor: Dr Elizabeth Price
|
SLE (Lupus) SIG
|
|
The Lupus SIG brings together clinicians, researchers, and allied health professionals with a shared interest in systemic lupus erythematosus and related connective tissue diseases. The group aims to facilitate collaboration, support clinical excellence, promote research, and provide educational opportunities to improve outcomes for people living with lupus.
Convenor: Edward Vital
|
Specialised commissioning in rheumatology SIG
|
|
This SIG aims to provide expert clinical advice and leadership to develop national commissioning polices and products, including facilitating implementation of NHS England’s specialised commissioning proposals, updating clinicians regarding NHS England’s specialised services including rheumatology, and sharing good practice.
Meetings are targeted at consultants, clinical nurse specialists and health professionals who provide a specialised rheumatology service.
Convenors: Dr Frances Hall
|
Spondyloarthritis SIG
|
|
|
Open to all healthcare professionals, trainees and scientists with an interesting in Spondyloarthritis, we meet annually at the BSR Conference for a multidisciplinary educational session and group update, but we also maintain an active mailing list to share relevant information on education, guidelines, and research. With over 250 members, we collaborate closely with the two key British societies in this field—BRITSpA (Axial Spondyloarthritis) and BritPACT (Psoriatic Arthritis)—to promote best practice and foster collaboration. If you are interested in joining, please contact the co-chairs by email: Dr Ben Thompson and Dr Pauline Ho.
|
Sustainability SIG
|
|
|
The Sustainability SIG aims to explore the impact healthcare has on the climate crisis, focusing on the role of Rheumatology and what clinicians in the speciality can do to contribute to the NHS’ ambition to reach Net Zero carbon emissions. It also aims to co-ordinate and streamline work being done in this area across the country. As a new SIG, we are still in the phase of setting up a regular meeting schedule. We aim to meet quarterly over the next year. We are planning an upcoming ‘launch’ meeting for anyone interested in joining the SIG. Sessions are predominantly online, with occasional face to face forums, usually at the annual conference. The agenda is flexible and can be shaped by our members and contributors. They will be split into a short ‘education’ section followed by a ‘business’ section. We are looking for people interested in becoming core members of the steering group and taking on leadership roles, but also for members to attend meetings without necessarily taking on roles if they prefer. The overall aim is to determine and shape how rheumatology as a speciality can contribute to tackling the climate crisis and put that into action. Within that, members will learn more about the links between healthcare and the climate crisis and what low carbon healthcare looks like. They will have an opportunity to help shape the vision of what this means for Rheumatology. Get in touch with one of the co-chairs to express your interest: Kieran Sandhu and Kalveer Flora
|
Telemedicine and remote monitoring SIG
|
|
The telemedicine and remote monitoring SIG provides a mechanism to share and disseminate best practice and experiences, as well as identifying important clinical and research priorities for this rapidly developing field. The group aims to provide a forum to facilitate the meeting of individuals with a special interest in telemedicine and remote monitoring in rheumatology.
The core objectives are to gather and share best practice and advances in telemedicine and relevant digital technologies in clinical practice and research (including issues and process of remote consent), to enhance rheumatology patient care, and develop educational materials and training sessions for the effective implementation of telemedicine and digital technologies into rheumatological healthcare settings.
The group works to identify barriers to patient and clinician uptake and identify methods to minimise barriers to uptake (including identifying strategies to avoid digital exclusion) and involve patients and patient representatives to ensure that the SIG agenda and priority setting remains aligned with both patients and healthcare professionals’ requirements.
Want to get involved? Contact convenors: Alexander Oldroyd, James Bateman, Philip Hamann
|
Ultrasound SIG
|
|
|
The Ultrasound SIG, was established over 15 years ago. It works closely with members of the BSR Education Committee and the BSR Education Team. The group has historically focussed on the education and training of rheumatology based ultrasound. This, in particular, has included the organisation of the annual BSR ultrasound courses and supporting clinical symposia. As such, the group has largely been composed of those who have been directly involved with these courses, especially with respect to course organisation or as a faculty member. As ultrasound has grown and become more mainstream, so has the number and type of practitioner using and performing it. Whilst a large number of our group are consultant rheumatologists, we are keen to grow the membership in terms of numbers, composition and geographic location. This includes rheumatology trainees, nurses, physiotherapists, podiatrists and radiographers. Membership is open to all BSR members and we aim to be as inclusive as possible. The group has typically communicated face-to-face at the AGM meetings and the BSR training courses. However, we plan to move to an on-line format for meetings e.g. via Teams in order to provide a forum for discussion. One of our major current priorities is the working towards the inclusion of ultrasound into our national rheumatology training curriculum. However, we also represent a network of clinical researchers and so this forum also offers the potential to be a platform for discussing and cooperating in research. The agenda for meetings will have standard items but there will be an opportunity to raise any new items prior to the agenda being set. The current SIG chair is Dr Richard Wakefield and so if you would like to join the group or you have any suggestions, please contact him in the first instance.
|
Vasculitis and PMR SIG
|
|
2025 marked the first annual conference for the newly combined Vasculitis and PMR SIG, bringing together prior ‘GCA and PMR’ and ‘Vasculitis’ SIGs under one banner. It is a professional network for clinicians, researchers, trainees, allied health professionals, and patient partners with a shared interest these fields. These conditions require early recognition, prompt treatment, and ongoing multidisciplinary care - the SIG is a platform to support these aims collaboratively.
The Vasculitis and PMR Special Interest Group (SIG) exists to support and promote high-quality clinical care and service delivery for patients with polymyalgia rheumatica (PMR) and vasculitis. The group fosters collaboration among professionals involved in the diagnosis, management, and research of these conditions and provides a valuable forum for knowledge exchange, clinical audit, and the development of guidelines. A key priority is engaging with patient organisations and advocacy groups to ensure that the patient voice remains central to all our activities.
Membership of the SIG offers a range of benefits, including the opportunity to network with peers and experts in the field of PMR and vasculitis. Members can take part in national discussions on clinical guidelines, service improvement, and research priorities, while also contributing to the development of educational events, policy positions, and patient pathways. SIG members gain early access to information on audits, research collaborations, and BSR-supported initiatives, as well as opportunities for career development through participation in national projects and leadership roles.
Contributions to discussions, working groups, or relevant projects are encouraged, with participation expected to be respectful, inclusive, and collaborative to help foster a supportive community.
We warmly welcome all members of the rheumatology and related clinical communities to get involved and help shape the future of PMR and vasculitis care in the UK. Join our mailing list or contact us via email at vascpmrsig@outlook.com.
|
Work and health SIG
|
|
This SIG aims to provide an opportunity for all those interested in health and work research, clinical practice and for dissemination of best practice in this field. The main aims of the SIG are to provide a forum for communication, information sharing and collaboration, continue to develop a body of literature about musculoskeletal interventions that enhance work participation and increase awareness of the importance of work as a health outcome.
|
|